1. Pink Sheet
  2. >>Geography

EMA Guide To Help Regulators Assess Subgroup Analyses In Confirmatory Trials

 
• By Vibha Sharma

A new final guidance by the European Medicines Agency outlines broad principles and strategies that regulatory assessors can use when investigating subgroups in confirmatory clinical trials.

Render illustration of Clinical Trial title on medical documents
EMA Guide Explains Importance Of Subgroup Analysis In Regulatory Decision-Making • Source: Shutterstock

The European Medicines Agency has issued guidance for assessors at EU regulatory agencies on how they should assess subgroup analyses in confirmatory clinical trials that are presented in marketing authorization applications.

The guideline - which may also be useful to clinical trial sponsors and regulatory assessors involved in providing scientific advice to companies - describes broad principles and assessment strategies and...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

Scientists Work With AI To Uncover ‘Unexpected’ Drug Combos for Breast Cancer

 
• By Natasha Barrow

A UK research team has used artificial intelligence to find new treatments for cancer using existing US Food and Drug Administration-approved medicines that are not normally not used for the disease.

EMA Official Clarifies Benefits And Limitations Of Innovation Pathways

 
• By Eliza Slawther

A European Medicines Agency official provided an overview and update of the support the EMA offers developers of innovative products and discussed, among other things, its Innovation Task Force, Quality Innovation Group and a scientific advice pilot for clinical trials.

EU Emergency Response Authority Needs Bigger Budget To Address Health Threats, Says Industry

 
• By Eliza Slawther

The EU must renew the mandate of its Health Emergency Response Authority to support medicine stockpiles and enable agile manufacturing to combat antimicrobial resistance and chemical, biological, radiological and nuclear threats, says trade organization EUCOPE.

How Pharma Companies Can Mitigate The Impact Of US Tariffs On The Supply Chain

 
• By Ewan Townsend

If US tariffs on pharmaceutical supply chain products come into force they could be disruptive for companies. Ewan Townsend, of the international law firm Arnold & Porter, explains how companies can mitigate issues through negotiating with suppliers and reallocating tariff responsibilities.

More from Geography